Clinical Trials Directory

Trials / Conditions / Cutaneous Lupus Erythematosus (CLE)

Cutaneous Lupus Erythematosus (CLE)

11 registered clinical trials studyying Cutaneous Lupus Erythematosus (CLE) — 8 currently recruiting.

StatusTrialSponsorPhase
RecruitingA Study of Enpatoran in Participants With Cutaneous Manifestations of Lupus With or Without Systemic Disease
NCT07332481
EMD Serono Research & Development Institute, Inc.Phase 3
Not Yet RecruitingEvaluate the Efficacy and Safety of ICP-488 in Subjects With Cutaneous Lupus Erythematosus (CLE) Double-blind
NCT07440537
Beijing InnoCare Pharma Tech Co., Ltd.Phase 2
Not Yet RecruitingStudy of S-4321 in Participants With an Autoimmune or Immune-mediated Disease
NCT07455578
Seismic Therapeutic AU Pty LtdPhase 1
Not Yet RecruitingThe Safety, Tolerability, Pharmacokinetics, Immunogenicity and Preliminary Efficacy of HC022 Injection in Subj
NCT07306585
HC Biopharma Inc.Phase 1
RecruitingA Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 2a Study With an Open-Label Extension Evalu
NCT07260877
Ventus Therapeutics U.S., Inc.Phase 2
Not Yet RecruitingLenalidomide vs Methotrexate in Difficult-to-treat Cutaneous Lupus Erythematosus
NCT06965244
Assistance Publique - Hôpitaux de ParisPhase 3
TerminatedStudy of Edecesertib in Participants With Cutaneous Lupus Erythematosus (CLE)
NCT05629208
Gilead SciencesPhase 2
Active Not RecruitingA Study of KK4277 in Healthy Volunteers and Patients With Systemic Lupus Erythematosus and Cutaneous Lupus Ery
NCT05411016
Kyowa Kirin Co., Ltd.Phase 1
RecruitingResearch Accelerated by You Lupus Registry
NCT06927219
Lupus Foundation of America—
CompletedEvaluation of Lenalidomide (REVLIMID®) to Treat Subjects With Cutaneous Lupus Erythematosus (CLE)
NCT00633945
University of PennsylvaniaN/A
RecruitingPrevalence and Clinical Severity of Cutaneous Lupus Erythematosus
NCT01510067
University of Pennsylvania—